All In MedTech

FDA Clearance Tracker · P140003-S107

Impella Ventricular Support Systems

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 29, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P140003-S107
Device name
Impella Ventricular Support Systems
Applicant
Abiomed, Inc.
Applicant location
Danvers, MA
Received
Oct 14, 2022
Decided
Mar 29, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P140003

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code OZD

FDA's approval statement

As written in FDA's record.

Approval for various modifications to the Instructions for Use to add the final results of the Post-Approval Study (PAS) protocol.

Source documents

Other decisions for Abiomed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.